Jade Biosciences, Inc. (JBIO)
19.90
-1.50
(-7.03%)
USD |
NASDAQ |
Sep 03, 15:44
Jade Biosciences Net Income (Quarterly) : -55.76M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -55.76M |
| March 31, 2026 | -40.37M |
| December 31, 2025 | -31.93M |
| September 30, 2025 | -25.18M |
| June 30, 2025 | -32.13M |
| March 31, 2025 | -38.17M |
| December 31, 2024 | -5.43M |
| September 30, 2024 | -16.28M |
| June 30, 2024 | -24.78M |
| March 31, 2024 | -23.19M |
| December 31, 2023 | -20.41M |
| September 30, 2023 | -19.56M |
| June 30, 2023 | -19.02M |
| Date | Value |
|---|---|
| March 31, 2023 | -16.52M |
| December 31, 2022 | -15.02M |
| September 30, 2022 | -13.59M |
| June 30, 2022 | -11.99M |
| March 31, 2022 | -10.91M |
| December 31, 2021 | -8.223M |
| September 30, 2021 | -6.184M |
| June 30, 2021 | -5.775M |
| March 31, 2021 | -2.781M |
| December 31, 2020 | -3.666M |
| September 30, 2020 | -2.307M |
| June 30, 2020 | -2.202M |
| March 31, 2020 | -1.436M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | -26.98M |
| Cue Biopharma, Inc. | -153.07M |
| Praxis Precision Medicines, Inc. | -83.72M |
| Opus Genetics, Inc. | -8.098M |
| Faeth Therapeutics, Inc. | -16.01M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 55.76M |
| EPS Diluted (Quarterly) | -0.7569 |
| Enterprise Value | 899.53M |
| Earnings Yield | -13.14% |
| Normalized Earnings Yield | -13.14 |